Press Release: Antitrust: Commission sends Statement of Objections to J&J and Novartis on delayed entry of generic pain-killer

Author (Corporate)
Series Title
Series Details IP/13/81 (31.01.13)
Publication Date 31/01/2013
Content Type

The European Commission has informed the pharmaceutical companies Johnson & Johnson (J&J, of the USA) and Novartis (of Switzerland) of its objections regarding an agreement concluded between their respective Dutch subsidiaries on fentanyl, a strong pain-killer. The Commission takes the preliminary view that the agreement delayed the market entry of a cheaper generic medicine in the Netherlands, in breach of EU antitrust rules. The sending of a Statement of Objections does not prejudge the final outcome of the investigation.
Source Link Link to Main Source http://europa.eu/rapid/press-release_IP-13-81_en.htm
Related Links
European Commission: MEMO/13/56: Antitrust: Commission enforcement action in pharmaceutical sector following sector inquiry http://europa.eu/rapid/press-release_MEMO-13-56_en.htm
Subject Categories ,
Countries / Regions